Phase IIA Single-Arm Study of Treatment of Patients with Advanced Liver Cancer with a Combination of TATE (Transarterial Tirapazamine Embolization) Followed by an Anti- PD-1 Monoclonal Antibody
Cancer - Colon,
Cancer - Liver,
Cancer - Rectum
BMS-936558, MDX-1106, Nivolumab, Pembrolizumab, Tirapazamine
For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email firstname.lastname@example.org.